Overview

A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The efficacy and safety of Cilostazol and Probucol in combination on patients with diabetic nephropathy is better than the single use.
Phase:
Phase 4
Details
Lead Sponsor:
Otsuka Beijing Research Institute
Treatments:
Cilostazol
Probucol